164 related articles for article (PubMed ID: 9160304)
41. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
42. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
Wong KK; Lu KH; Malpica A; Bodurka DC; Shvartsman HS; Schmandt RE; Thornton AD; Deavers MT; Silva EG; Gershenson DM
Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
[TBL] [Abstract][Full Text] [Related]
43. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases.
Takeshima Y; Amatya VJ; Kushitani K; Inai K
Am J Clin Pathol; 2008 Nov; 130(5):771-9. PubMed ID: 18854270
[TBL] [Abstract][Full Text] [Related]
44. Paratesticular cystadenomas with ovarian stroma, metaplastic serous Müllerian epithelium, and male adnexal tumor of probable wolffian origin: A series of 5 hitherto poorly recognized testicular tumors.
Michal M; Kazakov DV; Kacerovska D; Kuroda N; Lovric E; Wachter DL; Agaimy A; Hes O
Ann Diagn Pathol; 2013 Apr; 17(2):151-8. PubMed ID: 23020997
[TBL] [Abstract][Full Text] [Related]
45. Adenofibroma of the testis.
Gatt N; Attard J; Degaetano J
J Clin Pathol; 2009 Jun; 62(6):558-60. PubMed ID: 19474357
[TBL] [Abstract][Full Text] [Related]
46. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical profile of paratesticular serous papillary adenocarcinoma and tunica vaginalis facilitates distinction from malignant mesothelioma.
Anchala PR; Dhir R; Parwani AV; Zynger DL
Int J Surg Pathol; 2011 Oct; 19(5):692-8. PubMed ID: 19493919
[TBL] [Abstract][Full Text] [Related]
48. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract][Full Text] [Related]
49. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas.
Halperin R; Zehavi S; Dar P; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(4):292-6. PubMed ID: 11695812
[TBL] [Abstract][Full Text] [Related]
50. [Intratesticular papillary cystadenoma. A rare analogue of serous papillary cystadenoma of the ovary].
Meister P; Keiditsch E; Stampfl B
Pathologe; 1990 May; 11(3):183-7. PubMed ID: 2197619
[No Abstract] [Full Text] [Related]
51. Mucinous cystadenocarcinoma of the testis: a case report.
Iuga AC; Mull J; Batra R; Miller W
Hum Pathol; 2011 Sep; 42(9):1343-7. PubMed ID: 21396680
[TBL] [Abstract][Full Text] [Related]
52. Paratesticular papillary serous cystadenocarcinoma: a rare entity in Indian population.
Narang V; Sood N; Garg B; Aulakh BS
Indian J Pathol Microbiol; 2014; 57(4):614-6. PubMed ID: 25308020
[TBL] [Abstract][Full Text] [Related]
53. The relationship between papillary infarction and microinvasion in ovarian atypical proliferative ("borderline") serous and seromucinous tumors.
Kraus JA; Seidman JD
Int J Gynecol Pathol; 2010 Jul; 29(4):303-9. PubMed ID: 20567140
[TBL] [Abstract][Full Text] [Related]
54. Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.
Estrella JS; Wolf JK; Deavers MT
Arch Pathol Lab Med; 2013 Feb; 137(2):275-9. PubMed ID: 23368871
[TBL] [Abstract][Full Text] [Related]
55. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
[TBL] [Abstract][Full Text] [Related]
56. A rare case of serous papillary cystadenocarcinoma of the testis.
Leonardo C; Franco G; Michetti M; De Nunzio C; Zampelli A; De Dominicis C
J Androl; 2010; 31(5):434-6. PubMed ID: 20133965
[TBL] [Abstract][Full Text] [Related]
57. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors.
Komatsu T; Konishi I; Mandai M; Koshiyama M; Nanbu K; Yamamoto S; Kanzaki H; Rao CV; Mori T
Gynecol Oncol; 1995 Mar; 56(3):470-4. PubMed ID: 7705689
[TBL] [Abstract][Full Text] [Related]
58. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
Zafar R; Schrader LJ; Cheville JC; Schoolmeester JK; Roden AC; Aubry MC; Yi ES; Raghunathan A; Herrera-Hernandez L; Thompson RH; Boorjian SA; Leibovich BC; Keeney GL; Jimenez RE; Gupta S
Hum Pathol; 2022 Oct; 128():31-47. PubMed ID: 35809685
[TBL] [Abstract][Full Text] [Related]
59. Clear cell papillary cystadenocarcinoma of the epididymis: a case report and immunohistochemistry of markers for renal cell carcinoma.
Nozawa T; Konda R; Ohsawa T; Yoshida M; Komatsu M; Iwama T; Fujioka T
Histol Histopathol; 2013 Mar; 28(3):321-6. PubMed ID: 23348385
[TBL] [Abstract][Full Text] [Related]
60. Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison.
Wick MR; Mills SE; Dehner LP; Bollinger DJ; Fechner RE
Int J Gynecol Pathol; 1989; 8(3):179-88. PubMed ID: 2475447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
